These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6346907)

  • 1. Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants.
    Luchins DJ
    Am J Psychiatry; 1983 Aug; 140(8):1006-9. PubMed ID: 6346907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
    Veith RC; Raskind MA; Caldwell JH; Barnes RF; Gumbrecht G; Ritchie JL
    N Engl J Med; 1982 Apr; 306(16):954-9. PubMed ID: 7038497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is doxepin a safer tricyclic for the heart?
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    J Clin Psychiatry; 1991 Aug; 52(8):338-41. PubMed ID: 1869496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects.
    Goldman LS; Alexander RC; Luchins DJ
    J Clin Psychiatry; 1986 May; 47(5):225-9. PubMed ID: 3516976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of different tricyclic antidepressant drugs.
    Burrows GD; Vohra J; Hunt D; Sloman JG; Scoggins BA; Davies B
    Br J Psychiatry; 1976 Oct; 129():335-41. PubMed ID: 974441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of antidepressants.
    Cassem N
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):22-9. PubMed ID: 6816788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
    Ahles S; Gwirtsman H; Halaris A; Shah P; Schwarcz G; Hill MA
    J Clin Psychiatry; 1984 Nov; 45(11):460-5. PubMed ID: 6208185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.
    Glassman AH; Roose SP; Bigger JT
    JAMA; 1993 May; 269(20):2673-5. PubMed ID: 8487453
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular toxicity and tricyclic antidepressants.
    Jackson WK; Roose SP; Glassman AH
    Biomed Pharmacother; 1987; 41(7):377-82. PubMed ID: 3328632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants and the cardiac patient. Selecting an appropriate medication.
    Pary R; Tobias CR; Lippmann S
    Postgrad Med; 1989 Jan; 85(1):267-72, 274-6. PubMed ID: 2911542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular effects of tricyclic antidepressants].
    Sirota P; Ori I; Meshulam B; Zahavi I
    Harefuah; 1985 Aug; 108(3-4):94-9. PubMed ID: 3908239
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs.
    Vohra J; Burrows GD; Sloman G
    Aust N Z J Med; 1975 Feb; 5(1):7-11. PubMed ID: 1057916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of tricyclic and tetracyclic antidepressants.
    Burckhardt D; Raeder E; Müller V; Imhof P; Neubauer H
    JAMA; 1978 Jan; 239(3):213-6. PubMed ID: 579392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of bupropion in depressed patients with heart disease.
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    Am J Psychiatry; 1991 Apr; 148(4):512-6. PubMed ID: 1900980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
    Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of amitriptyline, nortriptyline, protriptyline, and doxepin in conscious rabbits after subacute pretreatment with protriptyline.
    Elonen E; Mattila MJ
    Med Biol; 1975 Aug; 53(4):238-44. PubMed ID: 1186320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of doxepin on the efficiancy of the human heart (author's transl)].
    Wolter H; Klepzig H; Frisch P
    Med Klin; 1977 Sep; 72(35):1392-401. PubMed ID: 333252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic antidepressants and cardiac conduction: changes in ventricular automaticity.
    Baum T; Peters JR; Butz F; Much DR
    Eur J Pharmacol; 1976 Oct; 39(2):323-9. PubMed ID: 824144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardiovascular toxicity of three tricyclic antidepressant drugs: imipramine, amitriptyline, and doxepin.
    Brown TC; Leversha A
    Clin Toxicol; 1979 Mar; 14(3):253-6. PubMed ID: 455914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular side effects of lithium].
    Albrecht J; Müller-Oerlinghausen B
    Dtsch Med Wochenschr; 1980 May; 105(18):651-5. PubMed ID: 6102902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.